Zhejiang Xinguang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 92.3 million compared to CNY 101.9 million a year ago. Revenue was CNY 92.3 million compared to CNY 101.9 million a year ago.

Net income was CNY 30.45 million compared to CNY 42.82 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.27 a year ago. Diluted earnings per share from continuing operations was CNY 0.19 compared to CNY 0.27 a year ago.